Disease characteristics in Belgian myelofibrosis patients and management guidelines anno 2013
Diagnostic and management guidelines for myelofibrosis patients are presented in this paper. As a consequence of the rapid evolution and progress in this domain over the last years, the need was felt by the BHS MPN subcommittee to update these guidelines for our country. The different prognostic scores in myelofibrosis, the diagnostic tools and treatment options with the focus on new possibilities are discussed.
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2013 |
Verlag/Hrsg.: |
Ariez International B.V.
|
Schlagwörter: | Guidelines / JAK2 inhibitors / Myelofibrosis / Prognostic scores |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26915263 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/213078 |